XML 201 R54.htm IDEA: XBRL DOCUMENT v3.26.1

Material Accounting Policies - Schedule of Subsidiaries of the Company (Details)	12 Months Ended
	Dec. 31, 2024
Cannahealth Ltd. (“Cannahealth”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Malta
Holding	100.00%
Functional Currency	EUR
Bophelo Holdings Ltd. (“Bophelo H”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	United Kingdom
Holding	100.00%
Functional Currency	GBP
Bophelo Bio Science and Wellness (Pty) Ltd. (“Bophelo”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Lesotho
Holding	100.00%
Functional Currency	LSL
Canmart Ltd. (“Canmart”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	United Kingdom
Holding	100.00%
Functional Currency	GBP
Holigen Holdings Limited (“Holigen”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Portugal
Holding	100.00%
Functional Currency	EUR
RPK Biopharma Unipessoal Lda. (“RPK”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Portugal	[1]
Holding	0.00%	[1]
Functional Currency	EUR	[1]
1371011 BC Ltd. ("1371011”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Canada
Holding	100.00%
Functional Currency	CAD
1468243 BC Ltd. (“1468243”) [Member]
Schedule of Subsidiaries of the Company [Line Items]
Country of Incorporation	Canada
Holding	100.00%
Functional Currency	CAD
[1] RPK was sold during the year ended December 31, 2024

X

- Definition

The description of subsidiaries functional currency.

+ References

No definition available.

+ Details

Name:	akan_FunctionalCurrency
Namespace Prefix:	akan_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 16
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_ii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_ii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 12
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_b&doctype=Standard
-URIDate 2025-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 19B
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_b&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 19B
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_CannahealthLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_BopheloHoldingsLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_BopheloBioScienceAndWellnessPtyLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_CanmartLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_HoligenHoldingsLimitedHoligenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_RPKBiopharmaUnipessoalLdaRPKMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_BCLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=akan_BCLtdOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: